|Mr. Stephen H. Rusckowski||Chairman, Pres & CEO||2.2M||13.79M||1957|
|Mr. Mark J. Guinan||Exec. VP & CFO||N/A||N/A||1962|
|Ms. Catherine T. Doherty||Sr. VP and Group Exec. of Clinical Franchise Solutions & Marketing||819.21k||1.1M||1963|
|Mr. James E. Davis||Exec. VP of Gen. Diagnostics||866.62k||2.97M||1963|
|Ms. Carrie Eglinton Manner||Sr. VP of Advanced Diagnostics||1.14M||N/A||1975|
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic testing information and services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also offers risk assessment services for the life insurance industry; and health information technology solutions for healthcare organizations and clinicians. Quest Diagnostics Incorporated has a strategic collaboration with hc1. The company was founded in 1967 and is headquartered in Secaucus, New Jersey.
Quest Diagnostics Incorporated’s ISS Governance QualityScore as of October 4, 2019 is 4. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 3; Compensation: 5.